No Image

CoImmune, Inc. to Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

DURHAM, N.C., Sept. 20, 2021 (GLOBE NEWSWIRE) — CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment using best-in-class cellular immunotherapies, today announced that Charles Nicolette, chief executive officer of CoImmune, will present a corporate update on September 23, 2021 at 9:05AM EDT during the virt...
read more
No Image

Kidoodle.TV® Levels Up Quantities of Kid-Friendly Gaming Content

The Safe Streaming™ service amasses huge gaming library of classic content and popular hits played by content creators CALGARY, Alberta, Sept. 20, 2021 (GLOBE NEWSWIRE) — A Parent Media Co. Inc. (APMC) is excited to share that its flagship product, Kidood...
read more
No Image

Ex-Goldman Sachs Partner Joins Crypto Unicorn Amber Group as CSO

HONG KONG, Sept. 20, 2021 (GLOBE NEWSWIRE) — Amber Group recently announced the appointment of former Goldman Sachs Partner Dimitrios Kavvathas as the firm’s new Chief Strategy Officer. In this new role, Dr. Kavvathas will work with Amber Group CEO Michael...
read more
No Image

WillScot Mobile Mini Acquires Three Leading Regional Storage Services Companies

PHOENIX, Sept. 20, 2021 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), a North American leader in modular space and portable storage solutions, today announced that it closed the acquis...
read more
No Image

Adagio Therapeutics Provides COVID-19 Antibody Program Updates as well as Business Highlights and Second Quarter 2021 Financial Results

New Data Supporting Potential of ADG20 for Both the Treatment and Prevention of COVID-19 to be Presented at IDWeek 2021 Patient Population in Global EVADE Phase 2/3 Clinical Trial of ADG20 Expanded following IDMC Assessment $355.8 Million IPO Completed to Fund...
read more
No Image

FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform

FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform MeMed BV is a first-of-its kind test that decodes the immune response to accurately distinguis...
read more
No Image

JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT €534 MILLION ($630 MILLION)

JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT €534 MILLION ($630 MILLION) Jeito I exceeds target and becomes the largest European fund dedicated to the life sciences sector Jeito Capital is dedi...
read more
No Image

Taiwan women’s tug of war team qualifies for 2022 World Games

Taiwan women's tug of war team finished fourth Sunday in the Closed Competition of the 2021 World Outdoor Championships, earning a berth in the 2022 World Games for the sport.The 12-member Taiwan team, which won the Open Club championship in the Women'...
read more
No Image

Over 155,000 foreign nationals eligible for Taiwan stimulus vouchers: NIA

More than 155,000 foreign nationals, mainly holders of Alien Permanent Resident Certificates (APRCs) and foreign spouses of Taiwanese citizens, will be eligible to obtain the government stimulus vouchers next month, the National Immigration Agency (NIA...
read more